YAREMA KRISTIN (President, Cell Therapy) reported 1 transaction at POSEIDA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/8/2025ACC: 0001415889-25-001080
Officer· President, Cell Therapy
Since Apr 2023
-1.46M
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
1.46M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−615.84K
Price / share
—
Trade value
—
% of position
New position
1/8/2025
615.84K→0.00
Total
Net shares
−615.84K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/8/2025 | U · U | −615.84K | — | — | New position | 615.84K | 0.00 |
| Total | −615.84K | $0.00 | ||||||
Derivative Transactions2
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
498.32K shares
Shares
−498.32K
Strike price
2.62
Held after
0.00
Exercisable
—
1/8/2025
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
345.20K shares
Shares
−345.20K
Strike price
3.38
Held after
0.00
Exercisable
—
1/8/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock498.32K shares | 1/8/2025 | D · Disposition | −498.32K | 2.62 | — | 0.00 |
| Employee Stock Option (Right to Buy) Direct | Common Stock345.20K shares | 1/8/2025 | D · Disposition | −345.20K | 3.38 | — | 0.00 |